【www.zhangdahai.com--述职述廉报告】
【摘要】 目的 比较不同诺和锐30注射方法对2型糖尿病疗效。方法 36例2型糖尿病口服药疗效不佳者随机分为两组，A组(18例)患者门冬胰岛素30三餐前皮下注射，B组(18例)患者门冬胰岛素30早晚餐前皮下注射。观察空腹血糖、餐后2 h血糖、糖化血红蛋白。结果 治疗3个月后A组餐后2 h血糖、糖化血红蛋白均低于B组，两组未发生严重低血糖及其他严重不良反应。结论 诺和锐30三次皮下注射减少血糖漂移，其临床疗效安全可靠。�
【关键词】 诺和锐30；2型糖尿病；血糖
�
Observation on two prescription methods ofNovorapid 30
PU Xiang-ling,SHEN He-rong.
Departmetn of Endocrinology,The Second People’s Hospital of Kunshan City Kunshan 215300,China
�
【Abstract】 Objective
To compare curative effect of two novorapid 30 with different injection method. Methods 36 cases of diabetics were divided into two groups randomly, A group (15 cases) were hypodermic injected novopapid 30 before three meals, and B group (15 cases) before breakfast and supper. Fasting blood glucose,2-hour postprandial blood glucose and glycosylated hemoglobin were recorded, respectively. Results The lever of 2-hour postprandial blood glucose, glycosylated hemoglobin in A group were lower than those in B group. There were not serious hypoglycemia and complication in either two groups. Conclusion It is safe and reliable for three times hypodermic injection，it can reduce blood glucose drift.�
【Key words】
Novorapid 30;type 2 diabetes;Blood sugor
2型糖尿病已经成为继心血管疾病、肿瘤之后的第三位严重危害人类健康的慢性疾病。餐后血糖波动更是糖尿病患者心脑血管直接和独立危险因素。随着人们健康意识的提高，胰岛素注射逐渐被患者接受。本研究观察诺和锐30三次给药与两次给药临床疗效。�
1 资料与方法�
1.1 一般资料 2009~2011年间住院2型糖尿病患者36例，男15例，女21例；年龄40~70岁体重48.5~80.5 kg，BMI 22~27 kg/m�2,病程2~15年。入选标准：①口服药血糖控制差，糖化血红蛋白(GHbA1) ＞8.0%。②无急性并发症。③无严重肝肾、心肺功能改变。�
1.2 研究方法 在饮食运动治疗的基础上，给予这36例患者随机分为两组。A组(18例)门冬胰岛素30三餐前皮下注射，B组(18例)门冬胰岛素30早晚餐前皮下注射。监测7点血糖，必要时加做2:00血糖，根据血糖调整用量。血糖达标后出院，门诊继续随诊满12周，观察治疗前后两组血糖、糖化血红蛋白。�
1.3 统计学方法 用SPSS 16.0统计软件，计量资料以x±s表示，采用t检验，P
